Mode
Text Size
Log in / Sign up

Weight Regain Reverses Caloric Restriction Benefits on Insulin-IGF-1 Pathway and Biological AgeWeight Regain Undoes Caloric Restriction Benefits For Diabetes Risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret weight regain as potentially reversing caloric restriction benefits on insulin-IGF-1 pathway and biological age; sustained loss is key.

This post hoc analysis of the 2-year Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy 2 (CALERIE-2) trial examined the consequences of weight regain on the insulin-IGF-1 nutrient-sensing pathway and biological age. The CALERIE-2 trial was a randomized controlled trial (RCT) that originally enrolled 220 participants, of whom 190 were available for this analysis. Participants were assigned to either a 25% caloric restriction (CR) intervention or a control diet. The intervention phase lasted 12 months, followed by a 12-month maintenance phase, for a total follow-up of 24 months. The setting of the trial was not reported.

During the intervention phase, weight loss ranged from 5.0 to 5.8 kg between groups at 12 months. Between months 12 and 24, most participants maintained weight (n = 112) or continued to lose weight (n = 58), whereas a smaller group regained more than 5% of baseline weight (n = 20). The primary outcome was the impact of weight regain on the insulin-IGF-1 nutrient-sensing pathway and biological age. Secondary outcomes included insulin area under the curve, ratio of insulin-like growth factor 1 (IGF-1) to insulin-like growth factor-binding protein 1, biological age, metabolic benefits, insulin resistance, and hormonal profiles linked to type 2 diabetes risk.

Results showed that weight regain reversed improvements in insulin area under the curve and the ratio of IGF-1 to IGF-binding protein 1. Sustained weight loss was associated with greater reductions in biological age. Exact effect sizes, p-values, and confidence intervals were not reported for these outcomes. The analysis was stratified by weight trajectory groups, and group differences were balanced using propensity score weighting.

Safety and tolerability data were not reported in this post hoc analysis. The study did not report adverse events, serious adverse events, or discontinuations.

Compared to prior landmark studies, the CALERIE-2 trial is one of the few long-term RCTs of caloric restriction in humans. This post hoc analysis extends findings by showing that weight regain can attenuate or reverse benefits on key regulators of the insulin-IGF-1 pathway and biological aging. However, the analysis is limited by its post hoc nature and the small number of participants who regained weight (n = 20).

Key methodological limitations include the post hoc design and the fact that participants were stratified by weight trajectory regardless of original randomization, though propensity score weighting was used to balance groups. The lack of reported p-values and confidence intervals for the main outcomes limits the ability to assess statistical significance. Additionally, the generalizability of findings to populations not in the CALERIE-2 trial is uncertain.

Clinically, these results suggest that substantial weight loss followed by weight regain can attenuate or reverse CR-induced benefits on the insulin-IGF-1 nutrient-sensing pathway and markers of biological aging. Sustained, moderate weight loss more effectively improves insulin resistance and maintains favorable hormonal profiles linked to type 2 diabetes risk and aging biology. Clinicians should emphasize the importance of sustained weight loss for long-term metabolic and aging benefits.

Several questions remain unanswered. The mechanisms by which weight regain reverses these benefits are not fully elucidated. The long-term effects beyond 2 years are unknown. Whether these findings apply to other populations, such as those with obesity or type 2 diabetes, requires further study. Additionally, the impact of different weight loss modalities (e.g., diet vs. exercise) on these pathways is not addressed.

Imagine you have finally lost weight after months of hard work. You feel lighter and more energetic. Then you gain those pounds back within a year. What happens to your body?

New research shows that regaining weight after a diet can undo the health benefits you worked so hard to achieve. This finding changes how we think about weight loss success.

Many people struggle with this cycle. They lose weight, feel great, and then slowly put the pounds back on. This pattern is common and frustrating for millions of adults.

The problem is that the body does not simply return to its starting state. The hormones that control blood sugar and aging can be permanently altered by this swing.

But here is the twist. The study found that the group that kept their weight off maintained the best health markers. The group that regained weight saw their progress fade quickly.

This matters because type 2 diabetes is a growing crisis. It affects people who are not necessarily obese but have insulin resistance. The body stops responding well to insulin.

Doctors have long known that losing weight helps. But they did not fully understand what happens when weight returns. This new data fills a major gap in our knowledge.

Our bodies use a complex system to sense how much food we eat. This system involves insulin and growth factors. Think of it like a factory that needs to run smoothly.

When you eat less, the factory slows down to save energy. This helps protect against diabetes. But when you eat more again, the factory speeds up.

The study used a specific analogy to explain this. It is like a traffic jam. Clearing the road helps traffic flow. But adding cars back creates a new jam.

The researchers looked at 220 people in a major trial. They watched them for two full years. Some lost weight and kept it off. Others lost weight and then gained it back.

They measured blood sugar levels and hormone ratios. They also checked a marker for biological age. This marker tells us how old our cells feel compared to our actual age.

The results were clear and surprising. Those who regained more than five percent of their starting weight lost their metabolic advantages. Their insulin levels went back up.

Sustained weight loss kept these benefits alive. It lowered the risk of developing type 2 diabetes. It also helped slow down the aging process at a cellular level.

This doesn't mean this treatment is available yet.

There is a catch though. The study was a post hoc analysis. This means they looked at data after the main trial ended. It is still early in the research timeline.

Experts say this fits into a bigger picture. We know that maintaining weight is hard. The body fights to return to its previous weight.

This research explains why that fight is so difficult. It is not just a lack of willpower. The biology itself pushes for weight regain.

What does this mean for you? If you lose weight, try to keep it off. Even small gains can hurt your progress. Talk to your doctor about maintenance plans.

The study had some limits. It involved a specific group of people. Not everyone reacts to weight changes the same way. More research is needed to confirm these results.

The road ahead involves better tools for weight maintenance. We need strategies that help people stay lean longer. This could change how doctors prescribe diets.

Future trials will likely focus on keeping weight off. They may test new drugs or behavioral tricks. The goal is to make weight loss stick.

Until then, the message is simple. Keep moving and keep eating well. Do not let the scale rise too high. Your hormones will thank you for it.

Study Details

Study typeRct
Sample sizen = 220
EvidenceLevel 2
Follow-up12.0 mo
PublishedMay 2026
View Original Abstract ↓
OBJECTIVE: To investigate the long-term metabolic and hormonal consequences of sustained weight loss versus weight regain after 1 year of caloric restriction (CR), with attention to insulin resistance and type 2 diabetes risk. RESEARCH DESIGN AND METHODS: In the 2-year Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy 2 (CALERIE-2) trial (n = 220), participants were randomized to 25% CR or control diet. The intervention targeted weight loss over the first 6-12 months, followed by a 12-month maintenance phase. To assess weight-regain consequences, participants were stratified by weight trajectory regardless of randomization, and group differences were balanced by propensity score weighting. Cardiometabolic and hormonal markers of available participants (n = 190), as well as a biomarker-based estimate of biological age, were compared across weight trajectory groups. RESULTS: At 12 months, weight loss ranged from 5.0 to 5.8 kg between groups. Between months 12 and 24, most participants either maintained weight (n = 112) or continued to lose weight (n = 58), whereas a smaller group regained >5% of baseline weight (n = 20). This group had the largest initial caloric reductions. Weight regain reversed improvements in insulin area under the curve and the ratio of insulin-like growth factor 1 (IGF-1) to insulin-like growth factor-binding protein 1, and sustained weight loss maintained metabolic benefits and was associated with greater reductions in biological age. CONCLUSIONS: Substantial weight loss followed by weight regain can attenuate or reverse CR-induced benefits on key regulators of the insulin-IGF-1 nutrient-sensing pathway and markers of biological aging. Sustained, moderate weight loss more effectively improves insulin resistance and maintains favorable hormonal profiles linked to type 2 diabetes risk and aging biology.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.